Company news
Scancell Holdings PLC news in 2018
Scancell Holdings PLC's news releases, calls and decks from 2018, newest first.
Scancell to Present at Two Conferences
November 12, 2018
Scancell to present at Proactive Investors Forum
November 1, 2018
Results of AGM
October 30, 2018
Identification of 2nd Moditope Cancer Vaccine
October 30, 2018
Update on SCIB1 Phase 2 Clinical Study
October 24, 2018
Final Results for the year ended 30 April 2018
September 25, 2018
Board Change
August 10, 2018
Agreement
August 9, 2018
Scancell exercises TriGrid commercial option
July 18, 2018
Grant of European patent for Moditope platform
May 23, 2018
Result of the Open Offer and PDMR Shareholdings
May 8, 2018
Result of Placing and Subscription and PDMR
April 18, 2018
Technology acquired from University of Nottingham
April 18, 2018
Proposed Placing, Subscription and Open Offer
April 18, 2018
Manufacturing agreement with The PolyPeptide Group
April 3, 2018
Scancell to present at the Calculus Investor Forum
February 16, 2018
Hardman Res. - Validating multiple opportunities
February 15, 2018
Collaboration agreement with ISA Pharmaceuticals
February 15, 2018
Publication highlights potential of SCIB1 therapy
February 12, 2018
European patent application allowed for grant
February 9, 2018
Scancell member of team shortlisted for CRUK award
February 8, 2018
Half-year Report
January 30, 2018
Scancell to collaborate with BioNTech
January 9, 2018
Decks in 2018
- LSX Inv€$tival Showcase 2018
Conference · 20 slides · Nov 13, 2018
- China Healthcare Summit 2018
Conference · 20 slides · November 2018
- Proactive One2One Biotechnology Forum (November 2018)
Conference · 27 slides · November 2018
- Shareholder Meeting (October 2018)
Shareholder meeting · 38 slides · Oct 30, 2018
- Investor Presentation (February 2018)
Investor deck · 58 slides · Feb 16, 2018